McKesson Co. (NYSE:MCK) Shares Acquired by Mather Group LLC.

Mather Group LLC. lifted its holdings in shares of McKesson Co. (NYSE:MCK) by 2.5% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 862 shares of the company’s stock after buying an additional 21 shares during the period. Mather Group LLC.’s holdings in McKesson were worth $491,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the business. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of McKesson by 206.7% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 460 shares of the company’s stock worth $269,000 after purchasing an additional 310 shares in the last quarter. Czech National Bank increased its position in shares of McKesson by 6.6% during the third quarter. Czech National Bank now owns 26,416 shares of the company’s stock worth $13,061,000 after purchasing an additional 1,645 shares in the last quarter. Kesler Norman & Wride LLC purchased a new stake in shares of McKesson during the third quarter worth approximately $404,000. Brookstone Capital Management increased its position in shares of McKesson by 15.2% during the third quarter. Brookstone Capital Management now owns 7,336 shares of the company’s stock worth $3,627,000 after purchasing an additional 968 shares in the last quarter. Finally, Gratus Wealth Advisors LLC increased its position in shares of McKesson by 5.1% during the third quarter. Gratus Wealth Advisors LLC now owns 5,267 shares of the company’s stock worth $2,547,000 after purchasing an additional 255 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Trading Up 0.3 %

MCK opened at $605.37 on Thursday. The stock’s 50-day moving average price is $590.03 and its 200 day moving average price is $562.26. McKesson Co. has a 12-month low of $464.42 and a 12-month high of $637.51. The firm has a market cap of $76.85 billion, a price-to-earnings ratio of 31.35, a PEG ratio of 1.29 and a beta of 0.52.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. On average, research analysts forecast that McKesson Co. will post 32.72 earnings per share for the current year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.47%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s payout ratio is 14.71%.

Wall Street Analyst Weigh In

MCK has been the subject of several research reports. StockNews.com upgraded McKesson from a “hold” rating to a “buy” rating in a research report on Wednesday, November 6th. Robert W. Baird upgraded McKesson from a “neutral” rating to an “outperform” rating and upped their target price for the company from $531.00 to $688.00 in a report on Thursday, November 7th. Citigroup dropped their target price on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Bank of America dropped their target price on McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a report on Monday, January 6th. Finally, Evercore ISI upped their target price on McKesson from $560.00 to $680.00 and gave the company an “outperform” rating in a report on Thursday, November 7th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $646.14.

Insider Buying and Selling

In other news, EVP Leann B. Smith sold 579 shares of McKesson stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $602.81, for a total value of $349,026.99. Following the completion of the transaction, the executive vice president now owns 1,443 shares in the company, valued at approximately $869,854.83. This trade represents a 28.64 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.11% of the stock is owned by corporate insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.